Positions

Overview

  • Dr. McCarty is a physician in Infectious Diseases at the University of Alabama at Birmingham and the Birmingham Veterans Affairs Medical Center (BVAMC). He also serves as co-director of antimicrobial stewardship at the BVAMC. Dr. McCarty's research interests include transplant infectious diseases, fungal infections, and antimicrobial stewardship.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 Amphotericin B Induction with Voriconazole Consolidation as Salvage Therapy for FKS-Associated Echinocandin Resistance in Candida glabrata Septic Arthritis and OsteomyelitisAntimicrobial Agents and Chemotherapy.  63. 2019
    2019 Impact of infectious disease consultation on clinical management and mortality in patients with candidemiaClinical Infectious Diseases.  68:1585-1587. 2019
    2018 Improvement of gram-negative susceptibility to fluoroquinolones after implementation of a pre-authorization policy for fluoroquinolone use: A decade-long experienceInfection Control and Hospital Epidemiology.  39:1419-1424. 2018
    2018 Echinocandin resistance among Candida isolates at an academic medical centre 2005-15: Analysis of trends and outcomesJournal of Antimicrobial Chemotherapy.  73:1677-1680. 2018
    2016 Invasive CandidiasisInfectious Disease Clinics of North America.  30:103-124. 2016
    2015 Cytomegalovirus appendicitis in solid organ transplant patients, two cases and a reviewJournal of Clinical Virology.  66:48-50. 2015
    2015 Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET)Medical Mycology.  53:440-446. 2015
    2014 The Evolving Epidemiology of SporotrichosisCurrent Fungal Infection Reports.  8:255-261. 2014
    2011 DiscussionAnnals of Thoracic Surgery.  91:1700-1701. 2011

    Investigator On

  • Private Grant  awarded by SERES THERAPEUTICS INC. 2018 - 2022
  • Private Grant  awarded by SERES THERAPEUTICS INC. 2018 - 2022
  • Private Grant  awarded by SCYNEXIS 2017 - 2021
  • Phase II Multi-Center, Prospective, Randomized, Double-Blind Study of Nitazoxanide in Acute and Chronic Norovirus in Hematpoietic Stem Cell and Solid Organ Transplant Recipients  awarded by Northwestern University 2016 - 2021
  • Private Grant  awarded by MAYNE PHARMA INC 2018 - 2021
  • Private Grant  awarded by CONTRAFECT CORPORATION 2018 - 2021
  • Private Grant  awarded by SUMMIT OXFORD LIMITED 2018 - 2021
  • Private Grant  awarded by CIDARA THERAPEUTICS, INC. - NEW 2016 - 2020
  • Private Grant  awarded by MERCK & COMPANY, INC. 2018 - 2020
  • Private Grant  awarded by VICAL, INC. 2018 - 2020
  • Private Grant  awarded by SHIRE PHARMACEUTICALS DEVELOPMENT, INC. 2017 - 2020
  • Prospective Observational Evaluation of the Association between the Day 2 Vancomycin Exposure and Failure Rates among Adult Hospitalized Patients with MRSA Bloodstream Infections (PROVIDE)  awarded by Duke University 2014 - 2019
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2013 - 2019
  • Private Grant  awarded by CRESTOVO LLC. 2017 - 2019
  • High VS. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients  awarded by VANDERBILT UNIVERSITY 2017 - 2019
  • Private Grant  awarded by SHIRE HUMAN GENETIC THERAPIES 2017 - 2019
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2016 - 2018
  • Private Grant  awarded by T2 BIOSYSTEMS 2016 - 2018
  • Private Grant  awarded by IMMUNO-MYCOLOGICS, INC. 2015 - 2018
  • B Cell Subsets and Infectious Immunity to Cryptococcosis  awarded by ALBERT EINSTEIN COLLEGE OF MEDICINE 2012 - 2018
  • Private Grant  awarded by ACTELION CLINICAL RESEARCH, INC. 2014 - 2017
  • A Prospective Cohort Study of Cryptococcus  awarded by Johns Hopkins University 2014 - 2017
  • Private Grant  awarded by ASTELLAS PHARMA US, INC. 2015 - 2017
  • Private Grant  awarded by SCYNEXIS 2014 - 2016
  • Private Grant  awarded by SERES THERAPEUTICS INC. 2015 - 2016
  • Private Grant  awarded by SERES THERAPEUTICS INC. 2015 - 2016
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2013 - 2015
  • Private Grant  awarded by CUBIST PHARMACEUTICALS 2014 - 2015
  • Education And Training

  • Doctor of Medicine, University of Alabama at Birmingham 2010
  • Bachelor of Science or Mathematics in Biology, University of Alabama at Birmingham 2005
  • UAB Hospital, Internship 2011
  • UAB Hospital, Residency 2013
  • UAB Hospital, Postdoctoral Fellowship 2015
  • Full Name

  • Todd McCarty